Scripta Insights Announces Fiduciary Protection Program to Protect Self-Insured Employers Against ERISA Lawsuits

Scripta's Rx Navigator, a price transparency tool, provides visibility into drug costs, enabling employers to lower costs, reduce legal exposure and enhance fiduciary oversight.

BOSTON, July 15, 2025 /PRNewswire/ -- Scripta Insights, the doctor-driven, AI-powered Rx Navigation™ company, announced today the launch of its Fiduciary Protection Program, designed to help self-insured employers stay compliant amid increased legal risks related to ERISA fiduciary responsibilities in prescription drug pricing.

The new program addresses the growing wave of ERISA lawsuits targeting employers over drug pricing mismanagement, providing unprecedented visibility into drug costs through Scripta's Rx Navigator price transparency tool. This innovative solution enables employers to demonstrate prudent fiduciary oversight, providing clear documentary evidence, while actively reducing prescription drug expenses for their organizations and employees.

"What Scripta does is industry-changing. Having an independent third party that reviews, 'Is this drug effective? What does it cost? Are there better options?' is huge," said Adam Russo, Esq., former SIIA Chair and CEO, The Phia Group, a leading provider of cost containment and legal expertise for self-insured health plans. "In an industry where many are incentivized to keep you in the system, a fresh set of eyes makes all the difference. That's why we use Scripta for our self-funded plan–if we recommend something to our clients, we believe in using it ourselves." The Phia Group has been a Scripta client since the very beginning in 2019.

"We're thrilled to offer Scripta's Fiduciary Protection Program to our clients because third-party tools like this are crucial for effective fiduciary protection," said Seth Friedman, Pharmacy and Health Plan Services Leader at Arthur J. Gallagher, a top U.S. benefits broker. "This independent, objective data empowers clients to act in the best interest of their members, protect against ERISA litigation risks, and strengthen their pharmacy management strategy—making it an essential tool in today's landscape."

Scripta's Fiduciary Protection Program helps self-insured employers fulfill their fiduciary duty through six essential components:

• Strengthened ERISA Fiduciary Compliance: Ensures employers act prudently in managing drug costs by providing independent, third-party drug alternatives and pricing data to members, while documenting cost-saving efforts.
• Optimized PBM Contract Negotiations & Accountability: Arms employers with data needed to negotiate better pricing terms with pharmacy benefit managers and helps ensure that employees and employers pay fair market prices for prescriptions.
• Comprehensive Cost Benchmarking: Compares drug prices across pharmacies and manufacturers, identifies pricing discrepancies, prevents overcharges, and provides defensible data to prove fiduciary prudence.
• Reduced Risk of Excessive Drug Spending: By identifying lower-cost alternatives and biosimilars, the program helps optimize prescription coverage policies and avoids lawsuits related to failure to manage excessive drug costs.
• Improved Employee Communication & Plan Transparency: Provides clear explanations of drug pricing to members, ensuring participants understand costs and giving them the tools they need to find lower-cost medication options.
• Strategic Rx Cost-Containment: Identifies alternatives to high-cost drugs and formulary inefficiencies, provides helpful data for implementing step therapy and prior authorizations, and delivers short and long-term cost savings without sacrificing quality.

"Prescription drug costs have become a major blind spot in employer-sponsored healthcare, exposing plan sponsors to significant legal and financial risks," said Eric Levin, CEO at Scripta Insights. "With our Fiduciary Protection Program, self-insured employers gain the transparency and actionable data they need to empower members, reduce costs, and safeguard against litigation."

Scripta's Rx Navigator puts the power of choice back in members' hands, revealing the complete set of prescription options. Employees and their enrolled dependents receive Personalized Savings reports, via app, web portal and mail, showing lower-cost options and potential savings. In the Scripta app, users can easily compare health plan and cash-pay prices, look up new meds, and get help making a prescription switch. The patient chooses how to save i.e. use a coupon, change pharmacies, or, if their doctor agrees, switch to a proven alternative.

Scripta allows patients to make smarter prescription decisions, adhere to necessary medications, lower out-of-pocket costs and improve health outcomes.

Scripta's Rx Monitor supports Rx Navigator clients by providing unique analytics and insights for payers to monitor their Rx benefit costs. Plan sponsors are able to contain their Rx benefit spend, optimize their benefits and support plan decision-making.

These Rx Navigation solutions integrate seamlessly with existing benefits systems. They work within a client's existing plan design and formulary, with all PBMs, and alongside any other Rx benefit cost containment solutions they may have in place.

Scripta is an independent, unbiased third party with unmatched clinical strength, flexibility, and transparent reporting–completely aligned with client goals.

About Scripta Insights
Scripta Insights, a venture-backed digital health company, is a leader in developing pharmacy navigation solutions for self-insured employers, health plans and their members. The company was founded in 2019, following nearly a decade of work by doctors, pharmacists and data analysts who helped build Scripta's proprietary software platform. For more information about Scripta, visit www.scriptainsights.com and follow the company on LinkedIn.

MEDIA CONTACT:
Linda Krebs
LKPR, Inc. for Scripta Insights
[email protected]
646-824-5186

SOURCE Scripta Insights